Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.14.5 extracted from

  • Pratley, R.E.; Jauffret-Kamel, S.; Galbreath, E.; Holmes, D.
    Twelve-week monotherapy with the DPP-4 inhibitor vildagliptin improves glycemic control in subjects with type 2 diabetes (2006), Horm. Metab. Res., 38, 423-428.
    View publication on PubMed

Application

Application Comment Organism
medicine monotherapy with vildagliptin is well tolerated and improves glycemic control in diet-treated subjects with type 2 diabetes Homo sapiens

Inhibitors

Inhibitors Comment Organism Structure
vildagliptin twelve-week monotherapy with the DPP-4 inhibitor vildagliptin improves glycemic control in subjects with type 2 diabetes Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Synonyms

Synonyms Comment Organism
dipeptidyl peptidase-4
-
Homo sapiens
DPP-4
-
Homo sapiens